Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2002
11/27/2002CN1382041A Direct comperession polymer tablet core
11/27/2002CN1382040A Therapeutic method
11/27/2002CN1382039A Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate
11/27/2002CN1382038A New and improved formulation for paclitaxel
11/27/2002CN1382037A Oral solution containing galanthamine and sweetening agent
11/27/2002CN1382036A Solubilized pharmaceutical composition for parenteral administration
11/27/2002CN1382034A Water-containing powder composition process for producing same and cosmetic preparation containing powder composition
11/27/2002CN1381512A Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine
11/27/2002CN1094755C Controlled release agent containing reamine benzene ring alcohol or it salt
11/26/2002US6486214 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
11/26/2002US6486213 Block and graft copolymers and methods relating thereto
11/26/2002US6486212 Semifluorinated alkanes and the use thereof
11/26/2002US6486208 Sustained release, and comfortable opthalmic composition and method for ocular therapy
11/26/2002US6486207 Compositions and methods for amelioration of human female sexual dysfunction
11/26/2002US6486200 Prodrugs for antimicrobial amidines
11/26/2002US6486182 Mutual prodrugs of amlodipine and atorvastatin
11/26/2002US6486152 Topical carbamazepine formulations and methods of use
11/26/2002US6486149 Dissolving crystalline cefditoren pivoxil substance and the water-soluble high-molecular additive in an aqueous solution of an acid, then neutralizing the resultant solution, to co-precipitate product, and drying
11/26/2002US6486144 Method of treatment of liver tumors and pharmaceutical compositions for use therein
11/26/2002US6486139 Ophthalmic solution comprising glycogen
11/26/2002US6486138 Ophthalmic compositions containing galactomannan polymers and borate
11/26/2002US6486124 Mixture of cyclosporin a and fatty ester
11/26/2002US6486106 Composition
11/26/2002US6485957 DNA encoding the human serine protease EOS
11/26/2002US6485932 Composition comprising immunoglobulin
11/26/2002US6485759 Botanical combinations for treating AIDS and immune-deficient patients to maintain good health and the process for preparing the same
11/26/2002US6485757 Method of producing a liquid enriched with plant substances, liquid formed thereby, and products formed therefrom
11/26/2002US6485755 Methods of using electron active compounds for managing cancer
11/26/2002US6485747 Prepared by spraying the tablet with an aqueous composition comprising from about 0.5 wt % to about 3 wt % gellan gum
11/26/2002US6485745 Dosage form exhibits accelerated release of the active agent
11/26/2002US6485743 Dissolved itraconazole and hydrophilic polymer with solvent, spray-dried, and prepared into solid dispersion for oral preparation
11/26/2002US6485742 Process for producing coated preparation and its use
11/26/2002US6485741 Tablets, capsules
11/26/2002US6485740 Transdermal methotrexate preparations
11/26/2002US6485733 Absorbent article composition for sequestering skin irritants
11/26/2002US6485726 Transepithelial delivery of antigens to provoke tolerance and immunity; the delivery of therapeutics conjugated to a fcrn binding partner to epithelium
11/26/2002US6485718 Converting a polypeptide containing a serine as its n-terminal amino acid to an aldehyde; converting the amine of a synthetic particle to a oxiamine; and combining aldehyde polypeptide to oxiamine
11/26/2002US6485707 Modulated release particles for aerosol delivery
11/26/2002US6485706 Dehydration product of insulin and an orally effective nonsteroidal membrane-permeation enhancer, for administration to buccal mucosa via spraying suspension of solid particles
11/26/2002US6485705 Dry pulverulent formulation comprising at least one film forming surfactant and a hydrophilic stabilizer in the presence of entrapable gas and an aqueous carrier phase mixable with said dry formulation
11/26/2002US6485704 Azo compound for type I pototherapy
11/26/2002CA2277017C Rapidly releasing and taste-masking pharmaceutical dosage form
11/26/2002CA2094277C Processing of yeast refuse and resulting product
11/26/2002CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065
11/26/2002CA2067184C New linker for bioactive agents
11/21/2002WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002WO2002092730A1 Process for the production of medicinal white oil using m41s and sulfur sorbent
11/21/2002WO2002092667A1 Biodegradable polyphosphates for controlled release of bioactive substances
11/21/2002WO2002092616A1 Antisense permeation enhancers
11/21/2002WO2002092558A1 Polythiourea lipid derivatives
11/21/2002WO2002092554A1 Complexes for transferring substances of interest into a cell
11/21/2002WO2002092217A1 Vegetable protein-based microcapsules
11/21/2002WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002WO2002092131A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002WO2002092130A1 Agent for improving tissue penetration
11/21/2002WO2002092116A1 Targeted delivery of drugs for the treatment of viral infections
11/21/2002WO2002092106A1 Taste masking pharmaceutical composition
11/21/2002WO2002092092A1 Minoxidil-containing liquid composition
11/21/2002WO2002092085A1 Pharmaceutical compositions comprising chelidonine or derivatives thereof
11/21/2002WO2002092082A1 Stable high-concentration injection containing pyrazolone derivative
11/21/2002WO2002092078A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
11/21/2002WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002WO2002092070A1 Isostearic acid salts as permeation enhancers
11/21/2002WO2002092069A1 Permeation enhancers
11/21/2002WO2002092061A1 Biorodible poly(orthoesters) from dioxolane-based diketene acetals
11/21/2002WO2002092060A1 Abuse-resistant controlled-release opioid dosage form
11/21/2002WO2002092059A1 Abuse-resistant opioid dosage form
11/21/2002WO2002092056A1 Compaction process for manufacture of sodium phenytoin dosage form
11/21/2002WO2002092055A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
11/21/2002WO2002092054A2 Immune modulation device for use in animals
11/21/2002WO2002092049A2 System for delivering cosmetics and pharmaceuticals
11/21/2002WO2002092008A2 Use of il-18 inhibitors for the treatement or prevention of sepsis
11/21/2002WO2002091996A2 Methods for treating cancer
11/21/2002WO2002091992A2 Targeted delivery of drugs for the treatment of parasitic infections
11/21/2002WO2002091991A2 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use
11/21/2002WO2002091989A2 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
11/21/2002WO2002091966A1 Kavalactone compositions and methods of use
11/21/2002WO2002091833A1 Prebiotic and probiotic compositions and methods for their use in gut-based therapies
11/21/2002WO2002074310A3 Stabilized formulation of selective ligands of retinoic acid gamma-receptors
11/21/2002WO2002072034A3 Chronotherapeutic dosage forms
11/21/2002WO2002064148A3 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
11/21/2002WO2002064108A3 Delivery of biologically active agents
11/21/2002WO2002062318A3 Oral itraconazole formulations and methods of making the same
11/21/2002WO2002058733A9 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
11/21/2002WO2002055720A3 Materials and methods relating to protein aggregation in neurodegenerative disease
11/21/2002WO2002055089B1 Immunoassay technique using multispecific molecules
11/21/2002WO2002043785A3 Intraocular implants for preventing transplant rejection in the eye
11/21/2002WO2002043765A3 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
11/21/2002WO2002040536A3 Acylated antimicrobial peptides
11/21/2002WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002WO2001034646A9 Recombinant gelatins
11/21/2002US20020173851 Intervertebral disc treatment devices and methods
11/21/2002US20020173736 Plaster containing 4-biphenylacetic acid
11/21/2002US20020173669 Steroid hormone products and methods for preparing them
11/21/2002US20020173643 Fusion protein delivery system and uses thereof
11/21/2002US20020173586 Thermogelling biodegradable aqueous polymer solution
11/21/2002US20020173552 Erodible polymers for injection
11/21/2002US20020173547 Pharmaceuticals compositions
11/21/2002US20020173516 Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye